Nirmal Bang Institutional Equities

SRF’s superior operating metrics compared to competitors and pharma companies, the global trend of countries seeking alternative supply opportunities outside of China, making India an option thanks to its relevant skillsets, and the heavy investment by India's specialty chemicals companies in expanding their capabilities, are reasons for the bullishness in this stock.

Brokerage firm Nirmal Bang sees favourable risk-reward in pharma

Pharma companies are likely to experience a recovery in margins, thanks to the easing of raw material costs and a reduction in price erosion in the US market.

New client addition slows down at top 4 Indian IT firms

TCS, Infosys, Wipro and HCL added 60 clients in the $1 million plus revenue band in Q1FY23, down from 91 clients added in the same band in Q1FY22

Here are some fundamental trading ideas from Rahul Arora

In an interview to Prashant Nair and Ekta Batra, Rahul Arora of Nirmal Bang Institutional Equities shared his views on the fundamentals of the market and the outlook going forward. He also spoke about specific stocks and sectors.

Here are top trading ideas from Rahul Arora

In an interview to CNBC-TV18's Prashant Nair and Sumaira Abidi, Rahul Arora, CEO at Nirmal Bang Institutional Equities shared his readings and outlook on market and specific stocks.

HCL Tech's Q3 show slightly better than peers: Experts

HCL Technologies, one of the largest software services providers, reported profit at Rs 2,062 crore on revenue of Rs 11,814 crore for the quarter. Its earnings matched expectations.

Price erosion won't impact generic cos in US: Dishman Pharma

Pharmaceutical stocks have been under the US FDA cloud. Will 2017 fare better? CNBC-TV18's Latha Venkatesh & Sonia Shenoy asks Arpit Vyas, MD of Dishman Pharmaceuticals & Chemicals, Surajit Pal of Prabhudas Lilladher and Vishal Manchanda of Nirmal Bang Institutional Equities.

After Baxter deal, Claris may opt for delisting: Nirmal Bang

Manchanda said he would like to hear from the management with regard to the distribution of the proceeds of the deal. If Claris' management decides to delist the company, it may opt for a share buyback as dividend payout involves distribution tax, he added.

Here are Rahul Arora's few investment ideas

In an interview to CNBC-TV18's Latha Venkatesh, Sonia Shenoy and Anuj Singhal, Rahul Arora, CEO, Nirmal Bang Institutional Equities and Abneesh Roy, Associate Director of Edelweiss Securities shared their readings and outlook Jubilant Foodworks. Rahul Arora also spoke on various stocks.

Here are a few investment ideas from Rahul Arora

In an interview to CNBC-TV18, Rahul Arora of Nirmal Bang Institutional Equities shared his readings and outlook on specific stocks and sector.

Here are some stock ideas from Rahul Arora

In an interview to CNBC-TV18, Rahul Arora, CEO of Nirmal Bang Institutional Equities shared his readings and outlook on specific stocks and sector.

Buy V-Guard Industries, says Rahul Arora

Rahul Arora, CEO at Nirmal Bang Institutional Equities recommends buying V-Guard Industries.

Here are some stock ideas from Rahul Arora

In an interview to CNBC-TV18's Ekta Batra and Anuj Singhal, Rahul Arora of Nirmal Bang Institutional Equities shared his readings and outlook on market and specific stocks.

Buy Swaraj Engines at around Rs 820-830: Rahul Arora

Rahul Arora, CEO at Nirmal Bang Institutional Equities is of the view that one can buy Swaraj Engines.

Buy Maruti Suzuki, says Rahul Arora

Rahul Arora, CEO at Nirmal Bang Institutional Equities recommends buying Maruti Suzuki.

Prefer Apar Industries: Rahul Arora

Rahul Arora, CEO at Nirmal Bang Institutional Equities is of the view that one may prefer Apar Industries.

Here are Rahul Arora's top trading ideas

Watch the interview of Rahul Arora, CEO, Nirmal Bang Institutional Equities with Reema Tendulkar & Anuj Singhal on CNBC-TV18, in which he shared his reading and outlook on market fundamentals and specific stocks and sectors.

Buy Jubilant Food; like Timken India, NRB Bearings: Rahul Arora

Watch the interview of Rahul Arora, CEO at Nirmal Bang Institutional Equities with Ekta Batra & Anuj Singhal on CNBC-TV18, in which he shared his readings and outlook on the market, specific stocks and sectors.

Buy Jubilant Foodworks, says Rahul Arora

Rahul Arora, CEO at Nirmal Bang Institutional Equities recommends buying Jubilant Foodworks.

Buy Lakshmi Machine Works, advises Rahul Arora

Rahul Arora, CEO at Nirmal Bang Institutional Equities is of the view that one can buy Lakshmi Machine Works.

Buy Colgate Palmolive, Procter and Gamble: Rahul Arora

Rahul Arora, CEO at Nirmal Bang Institutional Equities is of the view that one can buy Colgate Palmolive and Procter and Gamble Hygiene and Health Care.

Here are some top trading ideas from Rahul Arora

Watch the interview Rahul Arora, CEO at Nirmal Bang Institutional Equities with Latha Venkatesh & Anuj Singhal on CNBC-TV18, in which he shared his readings and outlook on market and specific stocks.

Top investment picks for 2016: Rahul Arora

Watch the interview of Rahul Arora, CEO at Nirmal Bang Institutional Equities with Anuj Singhal and Ekta Batra on CNBC-TV18, in which he shared top investment ideas for 2016.

IndusInd Bank, HDFC Bank, SKS Micro top bets: Rahul Arora

Rahul Arora, CEO of Nirmal Bang Institutional Equities is of the veiw that IndusInd Bank, HDFC Bank and Federal Bank are the top bets and feels that SKS Mircofinance can give 40-50 percent returns with a view of one year.